Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy:: experience from a large international series

被引:125
作者
Fischbach, W. [1 ]
Goebeler, M. E. [1 ]
Ruskone-Fourmestraux, A. [1 ]
Wuendisch, T. [1 ]
Neubauer, A. [1 ]
Raderer, M. [1 ]
Savio, A. [1 ]
机构
[1] Klinikum Aschaffenburg, Med Klin 2, D-63739 Aschaffenburg, Germany
关键词
D O I
10.1136/gut.2006.096420
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Eradication of Helicobacter pylori is the established initial treatment of stage I MALT ( mucosa associated lymphoid tissue) lymphoma. Patients with minimal persisting lymphoma infiltrates after successful eradication of H pylori are considered treatment failures and referred for radiation, chemotherapy, immunotherapy, or surgery. Aim: To report a watch and wait strategy in such patients. Methods: 108 patients were selected from a larger series of patients treated at various European institutions. Their mean age was 51.6 years ( 25 to 82), and they were all diagnosed as having gastric marginal zone B cell lymphoma of MALT type stage I. After successful H pylori eradication and normalisation of the endoscopic findings, lymphoma infiltrates were still present histologically at 12 months ( minimal histological residuals). No oncological treatment was given but the patients had regular follow up with endoscopies and multiple biopsies. Findings: Based on a follow up of 42.2 months (2-144), 102 patients (94%) had a favourable disease course. Of these, 35 (32%) went into complete remission. In 67 (62%) the minimal histological residuals remained stable and no changes became evident. Local lymphoma progression was seen in four patients (5%), and one patient developed a high grade lymphoma. Conclusions: Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of H pylori had a favourable disease course without oncological treatment. A watch and wait strategy with regular endoscopies and biopsies appears to be safe and may become the approach of choice in this situation. Longer follow up is needed to establish this definitively.
引用
收藏
页码:1685 / 1687
页数:3
相关论文
共 16 条
  • [1] REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION
    BAYERDORFFER, E
    NEUBAUER, A
    RUDOLPH, B
    THIEDE, C
    LEHN, N
    EIDT, S
    STOLTE, M
    [J]. LANCET, 1995, 345 (8965): : 1591 - 1594
  • [2] Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma
    Copie-Bergman, C
    Gaulard, P
    Lavergne-Slove, A
    Brousse, N
    Fléjou, JF
    Dordonne, K
    de Mascarel, A
    Wotherspoon, AC
    [J]. GUT, 2003, 52 (11) : 1656 - 1656
  • [3] Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori
    Fischbach, W
    Goebeler-Kolve, M
    Starostik, P
    Greiner, A
    Müller-Hermelink, HK
    [J]. LANCET, 2002, 360 (9332) : 547 - 548
  • [4] Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage
    Fischbach, W
    Goebeler-Kolve, ME
    Greiner, A
    [J]. GASTROINTESTINAL ENDOSCOPY, 2002, 56 (05) : 696 - 700
  • [5] Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy:: experience from a large prospective series
    Fischbach, W
    Goebeler-Kolve, ME
    Dragosics, B
    Greiner, A
    Stolte, M
    [J]. GUT, 2004, 53 (01) : 34 - 37
  • [6] Primary gastric B-cell lymphoma:: Results of a prospective multicenter study
    Fischbach, W
    Dragosics, B
    Kolve-Goebeler, ME
    Ohmann, C
    Greiner, A
    Yang, Q
    Böhm, S
    Verreet, P
    Horstmann, O
    Busch, M
    Dühmke, E
    Müller-Hermelink, HK
    Wilms, K
    [J]. GASTROENTEROLOGY, 2000, 119 (05) : 1191 - 1202
  • [7] Treatment results in localized primary gastric lymphoma: Data of patients registered within the German Multicenter Study (GIT NHL 02/96)
    Koch, P
    Probst, A
    Berdel, WE
    Willich, NA
    Reinartz, G
    Brockmann, J
    Liersch, R
    del Valle, F
    Clasen, H
    Hirt, C
    Breitsprecher, R
    Schmits, R
    Freund, M
    Fietkau, R
    Ketterer, P
    Freitag, EM
    Hinkelbein, M
    Heinecke, A
    Parwaresch, R
    Tiemann, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7050 - 7059
  • [8] T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication
    Liu, HX
    Ye, HT
    Ruskone-Fourmestraux, A
    De Jong, D
    Pileri, S
    Thiede, C
    Lavergne, A
    Boot, H
    Caletti, G
    Wündisch, T
    Molina, T
    Taal, BG
    Elena, S
    Thomas, T
    Zinzani, PL
    Neubauer, A
    Stolte, M
    Hamoudi, RA
    Dogan, A
    Isaacson, PG
    Du, MQ
    [J]. GASTROENTEROLOGY, 2002, 122 (05) : 1286 - 1294
  • [9] Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H-pylori eradication.: Lack of association with translocation t(11;18):: a 10-year updated follow-up of a prospective study
    Montalban, C
    Santón, A
    Redondo, C
    García-Cosi, M
    Boixeda, D
    Vazquez-Sequeiros, E
    Norman, F
    de Argila, CM
    Alvarez, I
    Abraira, V
    Bellas, C
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (09) : 1539 - 1544
  • [10] Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
    Neubauer, A
    Thiede, C
    Morgner, A
    Alpen, B
    Ritter, M
    Neubauer, B
    Wundisch, T
    Ehninger, G
    Stolte, M
    Bayerdorffer, E
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (18): : 1350 - 1355